Physician profile
Bauer E Sumpio
NPI 1750498671
$205,390.61
in general payments reported to CMS, 2019-2025
8 companies · $2,620 in 2025
The $2,620 reported for 2025 was more than what 75% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $100K · 2020: $6,578 · 2021: $28K · 2022: $41K · 2023: $27K · 2024: $305 · 2025: $2,620.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $15K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $10K · Travel and Lodging: $3,462 · Food and Beverage: $871.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $15,392.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,132.50 |
| Travel and Lodging | $3,462.16 |
| Food and Beverage | $871.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $99,567.06 | 2019-2023 | Prevena, Prevena Restor Bellaform, Prevena Restor Axioform |
| Janssen Pharmaceuticals, INC | $87,762.75 | 2019-2023 | Xarelto |
| Hypermed Imaging INC. | $13,034.61 | 2019 | |
| Solventum Corporation | $2,620.00 | 2025 | Prevena Restor Rotoform, Prevena Restor Axioform, Prevena |
| W. L. Gore & Associates, INC. | $2,103.00 | 2019-2024 | Gore Tag Conformable Thoracic Endoprosthesis |
| Cvrx, INC. | $121.92 | 2024 | Barostim Neo System |
| Bolton Medical INC | $105.89 | 2019 | |
| Silk Road Medical, INC. | $75.38 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bauer Sumpio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.